The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gray, Lachlan R ^a,b   Tachedjian, Gilda ^a,b   Ellett, Anne M ^a   Roche, Michael J ^a   Cheng, Wan Jung ^a   Guillemin, Gilles J ^d   Brew, Bruce J ^d   Turville, Stuart G ^e   Wesselingh, Steve L ^a,f   Gorry, Paul R ^a,b,c   Churchill, Melissa J ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; EFAVIRENZ; ETRAVIRINE; LAMIVUDINE; NEVIRAPINE; RALTEGRAVIR; STAVUDINE; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS G PROTEIN; VIRUS PROTEIN; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTE; CELL LINEAGE; CELL VIABILITY; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG POTENCY; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MONOCYTE; PSEUDOTYPING; VIRUS ENTRY; VIRUS INHIBITION;

ANTI-HIV AGENTS; ASTROCYTES; CELL LINE; HIV-1; HUMANS; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; ZIDOVUDINE;

CITRUS MAXIMA; HUMAN IMMUNODEFICIENCY VIRUS 1; VESICULAR STOMATITIS VIRUS;

EID: 84876172713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062196     Document Type: Article

References (36)

1. Gonzalez-Scarano F, Martin-Garcia J, (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81.
2. Cosenza MA, Zhao ML, Si Q, Lee SC, (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12: 442-455.
3. Churchill MJ, Gorry PR, Cowley D, Lal L, Sonza S, et al. (2006) Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J Neurovirol 12: 146-152.
4. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, et al. (2003) Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res 1: 463-473.
5. Thompson KA, Churchill MJ, Gorry PR, Sterjovski J, Oelrichs RB, et al. (2004) Astrocyte specific viral strains in HIV dementia. Ann Neurol 56: 873-877.
6. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, et al. (2009) Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 66: 253-258.
7. Wang Z, Trillo-Pazos G, Kim SY, Canki M, Morgello S, et al. (2004) Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 10Suppl 1: 25-32.
8. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, et al. (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65-70.
9. Letendre S, Ellis R, Deutsch R, Clifford D, Marra C, et al. (2010) Correlates of Time-to-Loss-of-Viral-Response in CSF and Plasma in the CHARTER Cohort. 17th Conference on Retroviruses and Opportunistic Infections (CROI). San Francisco, CA, USA.
10. Cysique LA, Vaida F, Letendre S, Gibson S, Cherner M, et al. (2009) Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 73: 342-348.
11. Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, et al. (2009) Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23: 1359-1366.
12. Letendre SL, Ellis RJ, Ances BM, McCutchan JA, (2010) Neurologic complications of HIV disease and their treatment. Topics in HIV medicine: a publication of the International AIDS Society, USA 18: 45-55.
13. Major EO, Traub RG, (1986) JC virus T protein during productive infection in human fetal brain and kidney cells. Virology 148: 221-225.
14. Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, et al. (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. Journal of neurochemistry 78: 842-853.
15. Gray L, Churchill MJ, Keane N, Sterjovski J, Ellett AM, et al. (2006) Genetic and functional analysis of R5×4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele. J Virol 80: 3684-3691.
16. Sterjovski J, Churchill MJ, Ellett A, Gray LR, Roche MJ, et al. (2007) Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Retrovirology 4: 89.
17. Yang X, Wyatt R, Sodroski J, (2001) Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol 75: 1165-1171.
18. Tyssen D, Henderson SA, Johnson A, Sterjovski J, Moore K, et al. (2010) Structure activity relationship of dendrimer microbicides with dual action antiviral activity. PloS one 5: e12309.
19. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, et al. (2001) Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity. J Virol 75: 10073-10089.
20. Drusano GL, Moore KHP, Kleim JP, Prince W, Bye A, (2002) Rational Dose Selection for a Nonnucleoside Reverse Transcriptase Inhibitor through Use of Population Pharmacokinetic Modeling and Monte Carlo Simulation. Antimicrobial agents and chemotherapy 46: 913-916.
21. Drusano GL, Bilello JA, Stein DS, Nessly M, Meibohm A, et al. (1998) Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables. The Journal of infectious diseases 178: 360-367.
22. Cysique LA, Maruff P, Brew BJ, (2004) Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 61: 1699-1704.
23. Volterra A, Meldolesi J, (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6: 626-640.
24. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ, (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17: 1539-1545.
25. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
26. Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, et al. (2010) Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 67: 552-558.
27. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17: 3-16.
28. Chun TW, Fauci AS, (1999) Latent reservoirs of HIV: obstacles to the eradication of virus. Proceedings of the National Academy of Sciences of the United States of America 96: 10958-10961.
29. Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, et al. (2012) Towards an HIV cure: a global scientific strategy. Nature reviews Immunology 12: 607-614.
30. Trono D, Van Lint C, Rouzioux C, Verdin E, Barre-Sinoussi F, et al. (2010) HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science 329: 174-180.
31. Schrager LK, D'Souza MP, (1998) Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA: the journal of the American Medical Association 280: 67-71.
32. Gorry P, Purcell D, Howard J, McPhee D, (1998) Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication. J Neurovirol 4: 377-386.
33. Li W, Galey D, Mattson MP, Nath A, (2005) Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotoxicity research 8: 119-134.
34. Mukherji E, Au JL, Mathes LE, (1994) Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells. Antimicrobial agents and chemotherapy 38: 1573-1579.
35. Perno CF, Yarchoan R, Cooney DA, Hartman NR, Gartner S, et al. (1988) Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides. The Journal of experimental medicine 168: 1111-1125.
36. de Almeida SM, Letendre S, Ellis R, (2006) Human immunodeficiency virus and the central nervous system. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 10: 41-50.